CommunitiesBreast Cancer Clinical TrialsAI in Clinical Trial Recruitment: A New Era of Equity?

AI in Clinical Trial Recruitment: A New Era of Equity?

SG

Community Member

3 years ago

Can AI usher in a new era of clinical trials, one where no patient is left behind, no opportunity is missed, and every stakeholder stands to gain? We want to bring our panel "Role of AI in Advancing Equitable Clinical Trial Recruitment" to SXSW. Please help us get there by voting for our panel! Voting ends soon! https://panelpicker.sxsw.com/vote/134817

PanelPicker | SXSW Conference & Festivals

panelpicker.sxsw.com

PanelPicker | SXSW Conference & Festivals

PanelPicker® is the official SXSW user-generated session proposal platform. Enter ideas and vote to help shape Conference programming for SXSW and SXSW EDU.

4
1 comment
Comment
accepted answer

Accepted Answer

This initiative highlights an important opportunity to improve how clinical trials reach diverse patient populations. AI technology has the potential to identify and connect patients with relevant studies more effectively, which could help address longstanding barriers to trial participation. The focus on equity is particularly meaningful for cancer patients who have historically faced challenges accessing clinical research opportunities. Voting for panels that advance these discussions can help bring more attention to solutions that benefit the entire cancer community.

3+ patients found this helpful

CA

Community Member

9 months ago

This initiative highlights an important opportunity to improve how clinical trials reach diverse patient populations. AI technology has the potential to identify and connect patients with relevant studies more effectively, which could help address longstanding barriers to trial participation. The focus on equity is particularly meaningful for cancer patients who have historically faced challenges accessing clinical research opportunities. Voting for panels that advance these discussions can help bring more attention to solutions that benefit the entire cancer community.

Outcomes4Me

© 2026 Outcomes4Me Inc. All rights reserved.